Rapid detection, cloning and molecular cytogenetic characterisation of sequences from an MRP-encoding amplicon by chromosome microdissection. by Ray, M. E. et al.
Br. I. Cancer (1994). 70, 85 90 © Macmillan Press Ltd. 1994
Rapid detection, cloning and molecular cytogenetic characterisation of
sequences from an MRP-encoding amplicon by chromosome
crodissection
M.E. Ray'-, X.-Y. Guan, M.L. Slovak", J.M. Trent' & P.S. Meltzer'
'Department ofHuman Genetics, The University ofMichigan Medical School, Mfedical Science II M4708, Ann Arbor, Michigan
48109, U'SA: ,Laboratorv ofCancer Genetics, .National Center for Human Genome Research, National Institutes ofHealth, 9000
Rockville Pike, Building 49, Room 4A 10, Bethesda, Martland 20892, U-SA: 3Department ofCvtogenetics, City ofHope National
Medical Center, 1500 East Duarte Road, Duarte, California 91010, L'SA.
Summarv Chromosome microdissection was utilised for the analysis of c togenetic markers of gene
amplification [homogeneously staining regions (hsrs) and double minutes (dmins)] in two doxorubicin-resistant
cell lines. fibrosarcoma HT1080 DR4 and small-cell lung cancer H69AR. Microdissection products from the
hsr(7Xpl2pl5) of HT1080 DR4 were amplified and used for fluorescent in situ hybridisation (micro-FISH)
analysis of drug-sensitive HT1080. resistant HT1080 DR4 and normal lImphocytes. The results demonstrated
that the hsr contains a domain of DNA amplification of complex origin including sequences dernved from
16pl1.2-16pl3.1. 2q1 1.2. 7q32-7q34 and 10q22. The amplification was confirmed by converting the micro-
dissected probe into a microclone library for probing HT1080 and HT1080 DR4 Southerns. A micro-FISH
probe from normal band region 16pl -16pl3 further demonstrated amplification of 16p sequences in both
HT1080 DR4 and H69AR. Dunrng the course of this analysis. Cole et al. (1992) (Science. 258, 1650-1653)
published the amplification of the MfRP gene in H69AR cells. which maps to chromosome 16pl3.1. Our
results corroborate the finding of MRP amplification in these doxorubicin-resistant cell lines. but. importantly.
they provide information on the composition of the complex amplicon contributions from four different
chromosomes. This study demonstrates the potential utility of chromosome microdissection for the rapid
recosers of sequences from amplified regions in drug-resistant cells.
Acquired resistance to chemotherapeutic agents is a fre-
quently encountered problem in cancer chemotherapy. Treat-
ment is often limited by the emergence of clonal tumour cell
populations that display resistance not only to the drugs used
in prior treatment. but to a wide range of chemotherapeutic
agents (Morrow & Cowan. 1993). Model systems based on
tumour cells selected in lvitro for increasing resistance to
chemotherapeutic agents have been useful in determining the
genetic and biochemical mechanisms of acquired drug resis-
tance. Acquisition of the drug-resistant phenotype in tissue
culture is frequently associated with amplification of specific
drug resistance genes (Kellems, 1993). Drug-resistant cells
which have undergone gene amplification frequently display
cytogenetic alterations such as homogeneously staining
regions (hsrs) or double minutes (dmins) which contain the
amplified target gene. For example, acquisition of the mul-
tiple drug-resistant phenotype is frequently associated with
amplification of the MDRI gene encoding the P-glycoprotein
transporter (Riordan et al., 1985; Ueda et al., 1986). Interest-
ingly. several cell lines with cross-resistance to multiple drugs
and which do not exhibit MDR1 amplification or P-glycopro-
tein overexpression have been reported (Beck et al., 1987;
McGrath & Center, 1987; Mirski et al., 1987: Slovak et al..
1988). It is likely that amplification of genes other than
MDRI may relate to drug resistance, and recently the gene
MRP has been reported to be amplified in P-glycoprotein-
negative cell lines (Cole et al., 1992; Slovak et al., 1993).
We have recently applied FISH analysis using probes
generated by chromosome microdissection (micro-FISH) to
the detection, cloning and identification of amplified
sequences from human tumours (Zhang et al.. 1993). We
sought to apply this technology to drug-resistant cell lines in
order to detect, clone and identify amplified sequences that
may be involved in the acquisition of the drug-resistant
phenotype.
Two drug-resistant cell lines were used in this study. The
doxorubicin-resistant fibrosarcoma cell line HT1080'DR4
displays an hsr(7)(p12pl5) which is not present in the paren-
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tal HT1080 cells (Slovak et al.. 1987). Similarly. the drug-
resistant small-cell lung carcinoma cell line H69AR (Mirski
et al.. 1987) developed an hsr and an increased number of
dmins relative to the parental cells. H69 (Slovak et al.. 1993).
These cell lines have been demonstrated to be negative for
MDRI amplification and P-glycoprotein overexpression. but
do have amplification and overexpression of the gene MRP
(which maps to l6pl3.l) (Cole et al.. 1992). Recent transfec-
tion expenments support a role for MRP in confemrng the
drug-resistant phenotype (personal communication from C.E.
Grant, S.P.C. Cole & R.G. Deeley). In this report, we ap-
plied chromosome microdissection to the hsr of HT1080
DR4. The results corroborate the high level of amplification
of 16p sequences within the hsr of HT1080 DR4. The utilisa-
tion of chromosome microdissection also allowed us to deter-
mine the complex nature of the MRP amplicon.
Materials and metbods
Cell culture
HT1080 parental and HT1080DR4 cell lines were cultured
as described by Slovak et al. (1987). H69 parental and
H69AR cell lines were kindly provided by S.P.C. Cole
(Queen's University, Kingston, Canada) and were cultured as
described by Mirski et al. (1987).
Microdissection andamplification ofchromosomal DNA
Cell metaphases were harvested and G-banded for micro-
dissection from tissue culture using conventional cytogenetic
techniques (Trent & Thompson, 1987). Microdissection was
performed with glass microneedles controlled by a micro-
manipulator attached to an inverted microscope as previously
described by Meltzer et al. (1992). The dissected chromosome
fragments were transferred to a 5 p1 collecting drop [contain-
ing 40 mM Tns-HCI. pH 7.5. 20 mM magnesium chlonrde.
50 mM sodium chlonrde, 200gM of each dNTP and 5 pmol of
universal primer (-CCGACTCGAGNNNNNNATGTGG-)].
A fresh microneedle was used for each fragment dissected.
For this libary. 20 hsr(7)(pl2pl 5) copies were dissected. after
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which the collection drop was covered with a drop of mineral
oil and incubated at 96°C for 5 min. An initial eight cycles of
polymerase chain reaction (PCR) (denaturation at 94°C for
1 min, annealing at 30°C for 2 min and extension at 37°C for
2 min) were conducted by adding approximately 0.3 units of
T7 DNA polymerase (Sequenase version 2.0, USB) at each
cycle. [Sequenase (13 units gi-') was diluted 1:8 in enzyme
dilution buffer (USB) and 0.2 gl was added to 5 gil of reac-
tion mixture.] Following this preamplification step, a conven-
tional PCR reaction catalysed by Taq DNA polymerase was
performed in the same tube. The components of the PCR
reaction were added to a final volume of 50 gil [10 mM
Tris-HCI, pH 8.4, 2 mM magnesium chloride, 50 mM potas-
sium chloride, 0.1 mg ml-' gelatin, 200 giM each dNTP and 2
units of Taq DNA polymerase (Perkin-Elmer/Cetus)]. The
reaction was heated to 95°C for 3 min followed by 35 cycles
at 94°C for 1 min, I min at 56°C and 2 min at 72°C, with a
5 min final extension at 72°C.
Fluorescent in situ hybridisation
Amplified microdissected DNA (2 gil) was labelled with
biotin-11-dUTP in a secondary PCR reaction identical to
that described above except for the addition of 20 giM biotin-
11-dUTP. The reaction was continued for 12 cycles of 1 min
at 94°C, 1 min at 56°C and 3 min at 72°C with a 10 min final
extension at 72°C. The products of this reaction were purified
with a Centricon-30 filter and used for FISH. Hybridisation
of the micro-FISH probes followed our procedure described
previously by Meltzer et al. (1992). For each hybridisation,
100 ng of probe was used in 10 gl of hybridisation mixture
containing 55% formamide, 2 x SSC and 1 gg of human Cot
I DNA (BRL). The slides with metaphase spreads were
denatured in 70% formamide, 2 x SSC, at 70°C for 2 min
and then hybridised with probes at 37°C in a moist chamber
overnight. After a series of washes and avidin/anti-avidin/
fluorescein isothiocyanate (FITC) treatments, the slide was
counterstained with 0.5 mg ml-' propidium iodide (including
an antifade solution) and examined with Zeiss Axiophot
microscope equipped with a dual bandpass (fluorescein/
rhodamine) filter.
Microcloning
A library of hsr(7)(pl2pl5) specific microclones was
generated essentially as described in Guan et al. (1992). The
PCR products were directly inserted into the T-tailed vector
pGEM-T (Promega). For this library, 100 ng of PCR pro-
ducts was ligated with 400 ng of vector in a 10 il volume
reaction at 12°C overnight. Ligation product (1 gil) was then
used to transform Escherichia coli by electroporation. Inserts
were recovered by PCR amplification of individual colonies
using vector primers (T7 and pUC/M13 reverse). Those
clones which hybridised to repetitive human Cot I sequences
were discarded and not used for Southern analyses.
Southern analyses
Southern hybridisation was performed using standard pro-
tocols. EcoRI-digested genomic DNA from HT1080 and
HT1080/DR4 was electrophoresed on 0.8% agarose gels and
transferred to nylon membranes (Zeta Probe, Bio-Rad). Blots
were UV cross-linked (Stratalinker, Stratagene) and, after a
prehybridisation of 4-6 h [at 45°C in 50% formamide,
1 x SET, 0.1% sodium pyrophosphate, 1% sodium dodecyl-
sulphate (SDS), 10% dextran sulphate, 200gg ml-' single-
stranded salmon sperm DNA], microclone probes were
[32P]dCTP labelled and added for hybridisation at 45°C over-
night. Blots were washed for approximately 1 h with 0.1 x
SSC, 0.1 % SDS, at 65°C. Autoradiographs were exposed
overnight at - 80°C before developing.
Results
Previously, cytogenetic analysis of the doxorubicin-resistant
cell line HT1O8O/DR4 demonstrated the acquisition of an
hsr(7)(pl2pl 5) during drug selection (Slovak et al., 1987,
Figure I Micro-FISH probe from HT1080/DR4 hsr(7)(p) hybridised to HT1080 interphase nuclei a, HT1080 metaphase
chromosomes b. HTI080/DR4 interphase nuclei c and HT 1080/DR4 metaphase chromosomes d. Note the increased probe
hybridisation to resistant cell chromatin and chromosomes. In d, the fluorescence signal is most intense on the HT1080/DR4
hsr(7)(p) but is also visible at several secondary sites.
.'iMIICRODISSECTION OF DRUG RESISTANCE CHROMOSOMES 87
1993). This marker appeared likely to carry amplified DNA
and was therefore targeted for microdissection. After
amplification of 20 microdissected fragments in vitro, the
product was biotinylated. This micro-FISH probe was then
hybridised to drug-resistant HT1080 DR4 and drug-sensitive
HT1080 parental cell interphase and metaphase nuclei. As
shown in Figure 1. increased fluorescent signal intensity was
observed in interphase nuclei of HT1080/DR4 (Figure lc)
relative to HT1080 (Figure la). On metaphase chromosomes.
the complex fluorescent signal in parental HT1080 (Figure
lb) localises to several sites, while the hybridisation pattern
in HT1080 DR4 metaphases (Figure ld) includes a highly
intense signal localised to the hsr(7)pl2pl5). These results
demonstrate that the probe recognises a chromosomal
domain consistent with the hsr(7)(pl2pl5) of HT1080,DR4.
and a comparison of HT1080 and HT1080 DR4 suggests
that the probe hybridises to sequences which are amplified in
HT1080 DR4 relative to the parental cell line.
Slovak et al. (1993) used a probe for the MRP gene to
document clearly the presence of MRP sequences within this
hsr. However, of interest, intervening blocks of chromosomal
DNA were observed which did not hybridise with either an
MRP probe or a whole chromosome composite painting
probe (WCP) for chromosome 16. In order to identify the
chromosomal origin of sequences in the hsr(7Xpl2pl5) we
examined the hybridisation pattern of the hsr(7)(pl2pl5)
micro-FISH probe to previously G-banded normal lympho-
cyte metaphases. As shown in Figure 2, the probe hybridised
to four discrete chromosome bands: 2ql l.2. 7q32-7q34.
1Oq22 and 16pl.2-16pl13.1. The signals on chromosome 16
and 7 were consistently strongest. Observation of multiple
metaphases suggested that the chromosome 16 signal was the
most intense. These results indicate that the hsr(7)(pl2pl5) of
HT1080 DR4 consists of amplified sequences from 16p (con-
sistent with the results of Slovak et al.. 1993) but also
contains sequences from 2q. 7q and 10q.
The micro-FISH probe from the HT1080 DR4 hsr(7)
(pl2pl5) was also hybridised to metaphase chromosomes of
H69AR. As shown in Figure 3. H69AR nuclei demonstrated
hybridisation to multiple intrachromosomal sites, including
both large marker chromosomes and smaller chromosomal
regions. Numerous double minutes within the same cells also
show hybridisation. The non-uniform hybridisation to the
large hsr markers may indicate the presence of sequences in
the H69AR amplicon not represented in the HT1080 DR4
hsr(7Xpl2pl5) probe. However, the positive hybridisation
signal clearly indicates a significant extent of overlap between
7!-
..
I
.
Figre 2 Micro-FISH probe from HT1080 DR4 hsr(7)(p) hy-
bridised to previously banded normal lymphocyte metaphases.
Hybridisation is apparent at 2q1 .2. 7q32-34. 10q22 and
16p1 1.2 - 13.1. Bright signals appear on 7q and 16p. and observa-
tion of multiple metaphases reveals that the 16p signal is
consistently the most intense. This result suggests that the micro-
dissected region contains sequences translocated from other sites
in addition to its major contribution from 16p.
sequences amplified in HT1080 DR4 and H69AR. This result
corroborates the results of Slovak et al. (1993) (who used a
16 WCP) and indicates that homologous sequences have been
amplified in two independently isolated doxorubicin-resistant
cell lines.
Because the HT1080,DR4 hsr(7)(pI2pl5) micro-FISH
probe was complex and the most intense signal localised to
band 16pl 1.2- 16pll3.1, we performed microdissection on this
segment in normal metaphases in order to investigate the
involvement of sequences from this region in the amplifi-
cation events in HT1080/DR4 and H69AR. A micro-FISH
probe specific for 16pll-16pl3 was hybridised to metaphase
chromosomes of HT1080 DR4 and H69AR. The results
shown in Figure 4 confirm that the amplicons in the H69AR
hsrs and some of the H69AR dmins as well as the hsr(7)
(pl2pl5) of HT1080,/DR4 contain sequences from the
16pl1- 16pl3 region. The localisation of the signals from the
l6pl l-6pI3 micro-FISH probe on HT1080DR4 and
H69AR chromosomes is in agreement with that of the
HT1080 'DR4 hsr(7Xpl2pl5) micro-FISH probe seen in
Figure ld and Figure 3. Interestingly, the probe displayed a
ladder-like' pattern of hybridisation to the hsr(7)(pl2pl5) of
HT1080/DR4, similar to the observations of Slovak et al.
(1993), who utilised a 16WCP. This is consistent with the
presence in the HT1080'DR4 hsr(7)(pl2pl5) of segments
derived from other chromosomal regions interspersed with
matenal from the I6pll-6pl3 region. Based on the results
in Figure 2. we conclude that these sequences are derived
from 2qI1.2. 7q32-7q34 and 10q22.
Fire 3 Two examples of H69AR cells hvbridised with the
HT1080 DR4 hsr(7Xp) micro-FISH probe. Hy-bridisation is ap-
parent to numerous double minutes (top. right-hand arrow) as
well as multiple intrachromosomal sites (other arrows). This
result suggests amplification of homologous sequences in H69AR
and HT1080 DR4. consistent with the results of Slovak et al.
(1993).88 M.E RAYonil!
Fue 4 A micro-FISH probe was generated from the normal
16pl1-16p13 region and hybnrdised to HT1080 DR4 a. and
H69AR b. metaphase nuclei. The results demonstrate amplifi-
cation of sequences from this region in both cell lines. Note the
striped appearance of the hybnrdisation pattern on the HT1080
DR4 hsr a. indicating interspersal of non-16pl 1-16pl3
sequences. Also note hybnrdisation to multiple H69AR
chromosomes b. hsrs (lower two arrows) and dmins b. (upper
arrow).
In order to characterise the amplification of DNA
sequences in the hsr(7)(pl2pl5) of HT1080 DR4. the
amplified microdissection products were converted into a
microclone libary. Thirty-five independent clones were
analysed. The insert size ranged from 200 to 700 bp. which is
consistent with previous microclone libraries constructed with
this methodology (Guan et al.. 1992). Six inserts were then
eliminated which hybridised with repetitive sequence probes.
The 29 remaining inserts were used as probes against
Southern blots of EcoRI-digested genomic HT1080 and
HT1080 DR4 DNA. Twenty-five of the 29 probes tested
(86%) detected amplified restriction fragments in HT1080
DR4 relative to HT1080. Representative examples are illus-
trated in Figure 5. It appeared that each amplification-
positive probe detected a different restriction fragment.
although some fragments were of similar size. Densitometn-
and DNA serial dilution expeniments revealed the level of
amplification of these microclones to be in the range of 5- to
10-fold, similar to that of MRP amplification in HT1080
DR4 (Slovak et al.. 1993). Six of the 25 microclones which
showed amplification in HT1080 DR4 w-ere also tested on
H69 and H69AR Southern blots. Three of these six detected
amplified restriction fragments in H69AR relative to H69
(data not shown). These results confirm that the amplified
product generated from microdissected chromosomal
material from the hsr contains sequences which are amplified
in HT1080 DR4 (as well as H69AR).
Discussion
Chromosome microdissection and microclone library con-
struction provide a novel approach for the rapid detection
and cloning of amplified DNA sequences from specific cyto-
genetically recognisable markers such as hsrs or dmins. Other
approaches to the analysis of amplified DNA sequences have
relied on techniques based on DNA electrophoresis such as
in gel renaturation and restriction landmark genomic scan-
ning (Roninson. 1983: Hatada et al.. 1991). These techniques
have successfully identified amplified sequences. but are
laborious and can be confounded by amplified sequences
unrelated to the phenotype of interest. The recently reported
molecular cytogenetic technique of comparative genome
hvbnidisation (CGH) is able to identify directly the
chromosomal origins of amplified sequences but does not
directly lead to the generation of cloned probes specific for
the amplicon (Kallioniemi et al.. 1992).
We sought to appil the technology of chromosome micro-
dissection to detect and clone amplified sequences from the
hsr(7)(pl2pl5) of the drug-resistant cel' line HT1080 DR4
because our previous attempts to obtain amplified sequences
from HT1080 DR4 by in-gel renaturation were unsuccessful
(Slovak et al.. 1991). Micro-FISH analysis utilising the probe
from the HT1080 DR4 hsr confirmed the presence of ampli-
fied sequences from 16p within the hsr (Slovak et al.. 1993).
but also enabled analysis of the chromosomal origins of
additional sequences within the amplicon. In addition to the
major contribution from 16pl1.2-16pl3.1. the hsr also
includes sequences from 2q 11.2. 7q32 -7q34 and 10q22. The
contribution of 16p w-as readily confirmed by hybridisation
of a 16pll-16pl3 micro-FISH probe from normal cells to
HT1080 DR4 and H69AR cells. Slovak et al. (1993) utilised
a chromosome 16 WCP for FISH analysis of the hsr(7)
(pl2pl5) of HT1080 DR4 as well as H69AR. They reported
the presence of chromosome 16 signals on multiple
chromosomes and dmins in H69AR and described a striped
pattern of fluorescent signal on the HT1080 DR4 hsr(7)
(pl2pl5). suggesting the presence of non-chromosome 16
sequences interspersed with chromosome 16 sequences u-ithin
the hsr. Our studies confirm that sequences from the specific
region of 16pll-16pl3 are amplified in both cell lines and
duplicate this 'ladder-like' fluorescent signal pattern on
HT1080 DR4 hsr(7Xpl2pl5). Our anal sis identifies the
chromosomal origins of the sequences u-hich are interspersed
with the l6pll -16p13 sequences as 2q'11.2. 7q32 -7q34 and
I0q22. The amplification of homologous sequences from 16p
in tu-o independently isolated doxorubicin-resistant cell
lineages strongly suggests that this region is inxolved in
acquisition of the drug-resistant phenotype. The roles of
sequences derived from other chromosomal origins in the
HT1080 DR4 hsr(7Xpl2pl5) remain uncertain. These se-
quences may represent a record of the chromosomal events
which led to the amplification of the 16p sequences. reflecting
upon amplification mechanisms. It is of interest to note that
2qlI.2 (FRA2A). 7q32.3 (FRA7H). 10q22.1 (FRAIOD) and
l6pl3.11 (FRA16A) are all fragile sites. which may increase
the likelihood of their involvement in chromosomal re-
arrangements (Reeders et al.. 1991; Simpson & Cann. 1991:
Spurr & White. 1991; Tsui & Farrall. 1991). However. it
remains possible that the chromatin interspersed between the
domains of 16p sequences contain genes which contribute to
the drug-resistant phenotype. Chromosome microdissection
will provide a valuable technique for further investigation of
the roles played by these sequences.
Of interest within the region of I6pl1 l6pl3. the gene
U11RP has been mapped to 16pl3.1 (Cole et al.. 1992) and
was cloned from H69AR. in which it is amplified and overex-
pressed. FISH analysis utilising MRP probes has demon-
strated that MRP is restricted to l6p13.1 in parental H69
and HT1080 cells but localises to the hsr(7)(pl2pl5) in
HT1080 DR4 and multiple hsrs and dmins in H69AR
(Slovak et al.. 1993). The sequence of the MRP product
shows homologY to the superfamily of transmembrane ATP-
dependent transport proteins. Recent transfection dataMICRODISSECTION OF DRUG RESISTANCE CHROMOSOMES 89
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Fugwe 5 Representative microclones from the HTl080/DR4 hsr(7Xp) library tested as probes on Southern blots. The majornty of
the non-repetitive clones in the library recognise restnction fragments which are amplified in HT1080/DR4 relative to HT1o8o. In
each blot, the left two lanes (labelled S) contain two dilutions of EcoRl-digested genomic DNA from HT1080 and the right two
lanes (labelled R) contain EcoRI-digested genomic DNa from HTI080/DR4. Approximate size markers appear to the right, while a
single-copy control probe hybridisation is shown below each blot.
support a role for the MRP product in conferring drug
resistance (personal communication from C.E. Grant, S.P.C.
Cole & R.G. Deeley).
Further clarification of the genetic events which have
occurred in the development of the HT1080/DR4 hsr(7)
(pl2pl5) will require more detailed physical mapping studies
of the amplified DNA. This will facilitate identification of all
of the genes encoded in the hsr so that their relationship to
the drug-resistant phenotype can be systematically evaluated.
In this regard, a significant advantage ofchromosome micro-
dissection-based technology is that, in addition to confirming
the presence of DNA sequence amplification and identifying
its chromosomal origin, it leads directly to the generation of
a microclone library which is highly enriched for amplifi-
cation unit probes. Eighty-six per cent of the non-repetitive
microclones tested showed significant amplification in
HT1080/DR4 relative to HT1080, and several showed
amplification in H69AR relative to H69 as well. These micro-
clones are valuable as entry point probes for the analysis of
the amplicon structure, and can be used to define the overlap
of the amplification units between independent drug-resistant
cell lines. Furthermore, these microclones are of a convenient
size for automated sequence analysis, which can be used to
establish sequence tagged sites (STSs) useful for the isolation
of large insert genomic clones such as yeast artificial
chromosomes (YACs). YAC clones can then be used to
establish a map of the amplicon in a manner similar to that
described by Schneider et al. (1992). In contrast to the map-
ping of the N-myc amplicon, for which numerous probes
previously existed, the physical mapping of amplicons from
newly identified amplification regions will be greatly
facilitated by techniques such as microdissection, which can
not only confirm the presence of amplified sequences at
specific chromosomal sites and identify the chromosomal
origins of those sequences, but also generate a library of
entry point probes for the initiation of amplicon structure
analysis.
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